Prime Medicine Inc — Quarterly Cash Flow (NASDAQ:PRME) | MetaTrader

Open full chart

Financials

Overview Relatórios Statistics Dividends

Quarterly Annual

Total assets 332.78 M297.51 M328.16 M279.01 M385.01 M Total liabilities 143.28 M144.36 M221.24 M218.15 M223.19 M Total equity 189.5 M153.15 M106.92 M60.86 M161.82 M Total liabilities & shareholders' equities 332.78 M297.51 M328.16 M279.01 M385.01 M Total debt ————— Net debt —————

Notícias

Vanda Pharmaceuticals (VNDA) Reports Q4 Loss, Lags Revenue Estimates

Prime Drink Group conclui primeira fase de captação por esforços restritos

Prime Drink Group completes first closing of private placement

Prime: Maintaining "Buy" On Solidified Catalysts For Wilson's Disease And Beyond

Prime Drink Group anuncia captação de até US$ 5 milhões por esforços restritos

Prime Drink Group announces private placement to raise up to $5 million

Goldman Sachs mantém classificação de biotecnologia em estágio inicial para ações da Prime Medicine

Goldman Sachs reiterates Early-Stage Biotech rating on Prime Medicine stock

Prime Medicine, Inc. (PRME) Reports Q3 Loss, Lags Revenue Estimates

Prime Medicine appoints Matthew Hawryluk as chief business officer

NovoCure (NVCR) Reports Q3 Loss, Tops Revenue Estimates

Prime Medicine Momentum Amid Pipeline Progress: Why I Choose To 'Hold' For Now (PRME)